These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

369 related items for PubMed ID: 11171994

  • 1. Vascular tumors in livers with targeted inactivation of the von Hippel-Lindau tumor suppressor.
    Haase VH, Glickman JN, Socolovsky M, Jaenisch R.
    Proc Natl Acad Sci U S A; 2001 Feb 13; 98(4):1583-8. PubMed ID: 11171994
    [Abstract] [Full Text] [Related]

  • 2. Inactivation of the arylhydrocarbon receptor nuclear translocator (Arnt) suppresses von Hippel-Lindau disease-associated vascular tumors in mice.
    Rankin EB, Higgins DF, Walisser JA, Johnson RS, Bradfield CA, Haase VH.
    Mol Cell Biol; 2005 Apr 13; 25(8):3163-72. PubMed ID: 15798202
    [Abstract] [Full Text] [Related]

  • 3. Inactivation of the tumor suppressor gene von Hippel-Lindau (VHL) in granulocytes contributes to development of liver hemangiomas in a mouse model.
    Bader HL, Hsu T.
    BMC Cancer; 2016 Oct 12; 16(1):797. PubMed ID: 27733136
    [Abstract] [Full Text] [Related]

  • 4. Up-regulation of hypoxia-inducible factors HIF-1alpha and HIF-2alpha under normoxic conditions in renal carcinoma cells by von Hippel-Lindau tumor suppressor gene loss of function.
    Krieg M, Haas R, Brauch H, Acker T, Flamme I, Plate KH.
    Oncogene; 2000 Nov 16; 19(48):5435-43. PubMed ID: 11114720
    [Abstract] [Full Text] [Related]

  • 5. Mutations of von Hippel-Lindau tumor-suppressor gene and congenital polycythemia.
    Pastore Y, Jedlickova K, Guan Y, Liu E, Fahner J, Hasle H, Prchal JF, Prchal JT.
    Am J Hum Genet; 2003 Aug 16; 73(2):412-9. PubMed ID: 12844285
    [Abstract] [Full Text] [Related]

  • 6. Reversion of deregulated expression of vascular endothelial growth factor in human renal carcinoma cells by von Hippel-Lindau tumor suppressor protein.
    Siemeister G, Weindel K, Mohrs K, Barleon B, Martiny-Baron G, Marmé D.
    Cancer Res; 1996 May 15; 56(10):2299-301. PubMed ID: 8625303
    [Abstract] [Full Text] [Related]

  • 7. The von Hippel-Lindau tumor suppressor gene.
    Kondo K, Kaelin WG.
    Exp Cell Res; 2001 Mar 10; 264(1):117-25. PubMed ID: 11237528
    [Abstract] [Full Text] [Related]

  • 8. Hepatic vascular tumors, angiectasis in multiple organs, and impaired spermatogenesis in mice with conditional inactivation of the VHL gene.
    Ma W, Tessarollo L, Hong SB, Baba M, Southon E, Back TC, Spence S, Lobe CG, Sharma N, Maher GW, Pack S, Vortmeyer AO, Guo C, Zbar B, Schmidt LS.
    Cancer Res; 2003 Sep 01; 63(17):5320-8. PubMed ID: 14500363
    [Abstract] [Full Text] [Related]

  • 9. von Hippel-Lindau gene-mediated growth suppression and induction of differentiation in renal cell carcinoma cells grown as multicellular tumor spheroids.
    Lieubeau-Teillet B, Rak J, Jothy S, Iliopoulos O, Kaelin W, Kerbel RS.
    Cancer Res; 1998 Nov 01; 58(21):4957-62. PubMed ID: 9810005
    [Abstract] [Full Text] [Related]

  • 10. Defective placental vasculogenesis causes embryonic lethality in VHL-deficient mice.
    Gnarra JR, Ward JM, Porter FD, Wagner JR, Devor DE, Grinberg A, Emmert-Buck MR, Westphal H, Klausner RD, Linehan WM.
    Proc Natl Acad Sci U S A; 1997 Aug 19; 94(17):9102-7. PubMed ID: 9256442
    [Abstract] [Full Text] [Related]

  • 11. Tracheal development and the von Hippel-Lindau tumor suppressor homolog in Drosophila.
    Adryan B, Decker HJ, Papas TS, Hsu T.
    Oncogene; 2000 Jun 01; 19(24):2803-11. PubMed ID: 10851083
    [Abstract] [Full Text] [Related]

  • 12. Von Hippel-Lindau syndrome. A pleomorphic condition.
    Friedrich CA.
    Cancer; 1999 Dec 01; 86(11 Suppl):2478-82. PubMed ID: 10630173
    [Abstract] [Full Text] [Related]

  • 13. VHL and PTEN loss coordinate to promote mouse liver vascular lesions.
    Chen S, Sanford CA, Sun J, Choi V, Van Dyke T, Samulski RJ, Rathmell WK.
    Angiogenesis; 2010 Mar 01; 13(1):59-69. PubMed ID: 20221685
    [Abstract] [Full Text] [Related]

  • 14. Role of transforming growth factor-alpha in von Hippel--Lindau (VHL)(-/-) clear cell renal carcinoma cell proliferation: a possible mechanism coupling VHL tumor suppressor inactivation and tumorigenesis.
    de Paulsen N, Brychzy A, Fournier MC, Klausner RD, Gnarra JR, Pause A, Lee S.
    Proc Natl Acad Sci U S A; 2001 Feb 13; 98(4):1387-92. PubMed ID: 11171960
    [Abstract] [Full Text] [Related]

  • 15. Coexpression of erythropoietin and vascular endothelial growth factor in nervous system tumors associated with von Hippel-Lindau tumor suppressor gene loss of function.
    Krieg M, Marti HH, Plate KH.
    Blood; 1998 Nov 01; 92(9):3388-93. PubMed ID: 9787178
    [Abstract] [Full Text] [Related]

  • 16. [Von Hippel-Lindau disease].
    Shuin T, Ashida S, Yao M, Kanno H.
    Nihon Rinsho; 2000 Jul 01; 58(7):1448-54. PubMed ID: 10921322
    [Abstract] [Full Text] [Related]

  • 17. Identification of novel hypoxia dependent and independent target genes of the von Hippel-Lindau (VHL) tumour suppressor by mRNA differential expression profiling.
    Wykoff CC, Pugh CW, Maxwell PH, Harris AL, Ratcliffe PJ.
    Oncogene; 2000 Dec 14; 19(54):6297-305. PubMed ID: 11175344
    [Abstract] [Full Text] [Related]

  • 18. Susceptibility to vascular neoplasms but no increased susceptibility to renal carcinogenesis in Vhl knockout mice.
    Kleymenova E, Everitt JI, Pluta L, Portis M, Gnarra JR, Walker CL.
    Carcinogenesis; 2004 Mar 14; 25(3):309-15. PubMed ID: 14604887
    [Abstract] [Full Text] [Related]

  • 19. Allelic deletions of the VHL gene detected in multiple microscopic clear cell renal lesions in von Hippel-Lindau disease patients.
    Lubensky IA, Gnarra JR, Bertheau P, Walther MM, Linehan WM, Zhuang Z.
    Am J Pathol; 1996 Dec 14; 149(6):2089-94. PubMed ID: 8952541
    [Abstract] [Full Text] [Related]

  • 20. Alternate choice of initiation codon produces a biologically active product of the von Hippel Lindau gene with tumor suppressor activity.
    Blankenship C, Naglich JG, Whaley JM, Seizinger B, Kley N.
    Oncogene; 1999 Feb 25; 18(8):1529-35. PubMed ID: 10102622
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 19.